Records 1 - 5
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy.
Translational lung cancer research 2020 Dec 9 (6): 2367-2379.
Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y
| Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
Lung cancer (Amsterdam, Netherlands) 2018 Jun 120 113-121.
Du Meijun, Thompson Jonathan, Fisher Hannah, Zhang Peng, Huang Chiang-Ching, Wang Lia
| Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.
BMC cancer 2016 16 (1): 28.
Samulin Erdem Johanna, Skaug Vidar, Bakke Per, Gulsvik Amund, Haugen Aage, Zienolddiny Shanb
| Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.
PloS one 2014 9 (4): e95303.
Toschi Luca, Finocchiaro Giovanna, Nguyen Teresa T, Skokan Margaret C, Giordano Laura, Gianoncelli Letizia, Perrino Matteo, Siracusano Licia, Di Tommaso Luca, Infante Maurizio, Alloisio Marco, Roncalli Massimo, Scorsetti Marta, Jänne Pasi A, Santoro Armando, Varella-Garcia Marilei
| Increased Sox2 copy number in lung squamous cell carcinomas.
Experimental and therapeutic medicine 2012 Jan 3 (1): 44-48.
Sasaki Hidefumi, Yokota Keisuke, Hikosaka Yu, Moriyama Satoru, Yano Motoki, Fujii Yoshita